Should We Focus on Novel Risk Markers and Screening Tests to Better Predict and Prevent Cardiovascular Disease?
Article first published online: 22 SEP 2010
© 2010 Wiley Periodicals, Inc.
Volume 13, Issue 4, pages 152–159, Fall 2010
How to Cite
Enriquez, J. R. and De Lemos, J. A. (2010), Should We Focus on Novel Risk Markers and Screening Tests to Better Predict and Prevent Cardiovascular Disease?. Preventive Cardiology, 13: 152–159. doi: 10.1111/j.1751-7141.2010.00080.x
- Issue published online: 22 SEP 2010
- Article first published online: 22 SEP 2010
- Manuscript received July 9, 2010; accepted July 19, 2010
- 4ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women’s Health Research. J Am Coll Cardiol. 2009;54:1364–1405., , , et al.
- 8Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2010.
- 11Remaining lifetime risks for cardiovascular disease death by risk factor burden at selected ages in black and white men and women. Circulation. 2007;116:832., , , et al.
- 23Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation. 2006;114:201–208., , , et al.